{"member_organisations": "http://pptaglobal.org/membership/current-members", "identification_number": "687559214721-11", "fields_of_interest": "Economy, finance and the euro, Trade, Competition, Employment and Social Affairs, Business and Industry, Taxation, Single market, Research and innovation, Public Health", "head_office_address": "Boulevard Brand Whitlock, 114/4", "full_time_equivalent_fte": "1,5", "person_with_legal_responsibility": "Bruno Santoni", "inter_groups": "", "financial_year_start_date": "01/01/2016", "grants": "", "head_office_country": "Belgium", "eu_initiatives": "DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsand amending Directive 2001/83/EC \n \nDIRECTIVE 2004/23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells \n \nEU Commission Evaluation of EU OMP Regulation and Paediatrics Regulation", "organisation_name": "Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose (PPTA Europe aisbl)", "belgium_office_post_code": "", "number_of_persons_involved": "3", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "number_of_ep_accredited_persons": "1", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "PETROVSKY#Karl", "estimate_of_costs_absolute_amount": "", "registration_date": "20/10/2014", "website_address": "http://www.pptaglobal.org", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Brussels", "membership": "", "head_office_post_code": "1200", "goals__remit": "The mission of the Plasma Protein Therapeutics Association (PPTA) is to promote the availability of and access to safe and effective plasma protein therapeutics for all patients in the world. We will strive to achieve our mission by: \n \nFostering the collection of high-quality plasma from healthy donors; \n \nEstablishing standards for the manufacturing of life-saving plasma protein therapies at the highest levels of safety and quality; \n \nBreaking down artificial barriers on trade and compensated donors that limit patient access to therapy; \n \nSupporting government reimbursement practices that reflect the unique nature of plasma protein therapies; \n \nEducating all stakeholders about the value of the therapies; and \n \nAdhering to the PPTA Code of Ethics.", "industry_forums": "", "head_office_phone": "(+32)27055811", "level_of_interest": "European, global", "relevant_communication": "http://pptaglobal.org/presentations-publications/presentations \n \nhttp://pptaglobal.org/presentations-publications/publications", "financial_year_end_date": "01/12/2016", "estimate_of_costs_as_a_range": "300000-399999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Non-for-profit organization", "person_in_charge_of_eu_relations": "Karl Petrovsky", "customers": "", "belgium_office_post_box": "", "position": "Senior Manager Health Policy Europe"}